Baxter exec reports initial stock and option stakes

Baxter International executive Julie Foster, President of Front Line Care, filed an initial ownership report showing both stock and option holdings.

Accepted by SEC EDGAR 04/09/2026 - 04:14 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Baxter International executive Julie Foster, President of Front Line Care, filed an initial ownership report showing both stock and option holdings. She directly holds 31,248 shares of common stock and a stock option covering 25,862 shares at an exercise price of $20.37 per share, expiring on February 27, 2036. The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Foster Julie

Role President, Front Line Care

Type	Security	Shares	Price	Value
Holding	Stock Option (Right to Buy)	--	--	--
Holding	Common Stock, $1 par value	--	--	--

Holdings: Stock Option (Right to Buy) — 25,862 contracts (Direct); Common Stock, $1 par value — 31,248 shares (Direct)

Footnotes (1)

1. F1. The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.

Key Figures

Direct common shares: 31,248 shares Option underlying shares: 25,862 shares Option exercise price: $20.37/share +2 more

5 metrics

Direct common shares 31,248 shares Total common stock held directly after reported holdings

Option underlying shares 25,862 shares Underlying Baxter common shares for reported stock option

Option exercise price $20.37/share Exercise price of stock option (Right to Buy)

Option expiration February 27, 2036 Expiration date for reported stock option

Option vesting start March 1, 2027 First vesting date; three equal annual installments

Key Terms

Stock Option (Right to Buy), Common Stock, $1 par value, exercise price, exercisable in three equal annual installments, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)" tied to Baxter common stock"

Common Stock, $1 par value financial

"security_title: "Common Stock, $1 par value" for Baxter shares held directly"

exercise price financial

"conversion_or_exercise_price of 20.3700 indicates the option exercise price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

exercisable in three equal annual installments financial

"footnote states options become exercisable in three equal annual installments"

grant date financial

"footnote notes March 1, 2027 is the first anniversary of the grant date"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filing by Baxter (BAX) executive Julie Foster show?

The Form 3 shows Julie Foster’s initial ownership in Baxter, including 31,248 common shares and stock options for 25,862 underlying shares at $20.37. It establishes her baseline equity position as President, Front Line Care.

How many Baxter (BAX) common shares does Julie Foster directly own?

Julie Foster directly owns 31,248 shares of Baxter common stock. This figure reflects her direct equity stake reported on the Form 3 and serves as a starting reference for any future reported transactions.

What stock options in Baxter (BAX) does Julie Foster hold?

Julie Foster holds a stock option labeled “Stock Option (Right to Buy)” tied to 25,862 underlying Baxter common shares at an exercise price of $20.37. These options provide the right, but not the obligation, to buy shares at that price.

When do Julie Foster’s Baxter (BAX) stock options vest?

The options become exercisable in three equal annual installments beginning March 1, 2027. That date is the first anniversary of the grant, so vesting is spread over three years from that point, according to the disclosed footnote.

When do Julie Foster’s Baxter (BAX) stock options expire?

The reported stock option position expires on February 27, 2036. This expiration date defines the final day by which the options must be exercised, after which they lapse and can no longer be used to purchase shares.

Does Julie Foster’s Form 3 indicate recent buying or selling of Baxter (BAX) shares?

The Form 3 reflects holdings rather than specific buy or sell transactions. It lists existing common stock and option positions, establishing her ownership baseline as a newly reported insider without detailing recent trading activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Foster Julie

(Last) (First) (Middle)

ONE BAXTER PARKWAY

(Street)

DEERFIELD ILLINOIS 60015

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2026

3. Issuer Name and Ticker or Trading Symbol
BAXTER INTERNATIONAL INC [ BAX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Front Line Care

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $1 par value	31,248	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	02/27/2036	Common Stock, $1 par value	25,862	$20.37	D

Explanation of Responses:

1. The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.

Remarks:

	/s/ Kimberly Olson, as attorney in-fact for Julie Foster	04/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)